adefovir has been researched along with 6-phosphonylmethoxyethoxy-2,4-diaminopyrimidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrei, G; Balzarini, J; De Clercq, E; Holý, A; Masojídková, M; Naesens, L; Snoeck, R; Votruba, I | 1 |
| Andrei, G; Balzarini, J; De Clercq, E; Hocková, D; Holý, A; Masojídková, M; Snoeck, R | 1 |
| Andrei, G; De Clercq, E; Holy, A; Krecmerová, M; Lebeau, I; Snoeck, R | 1 |
| Baba, M; De Clercq, E; Shi, M; Takao, S; Wang, X | 1 |
| Andrei, G; Crance, JM; De Clercq, E; De Vos, R; Duraffour, S; Garin, D; Holy, A; Krecmerová, M; Snoeck, R; van Den Oord, J | 1 |
| Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
| Camarasa, MJ; de Castro, S | 1 |
1 review(s) available for adefovir and 6-phosphonylmethoxyethoxy-2,4-diaminopyrimidine
| Article | Year |
|---|---|
Polypharmacology in HIV inhibition: can a drug with simultaneous action against two relevant targets be an alternative to combination therapy?
Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; HIV; Humans; Microbial Sensitivity Tests; Molecular Structure; Polypharmacology | 2018 |
6 other study(ies) available for adefovir and 6-phosphonylmethoxyethoxy-2,4-diaminopyrimidine
| Article | Year |
|---|---|
6-[2-(Phosphonomethoxy)alkoxy]pyrimidines with antiviral activity.
Topics: Animals; Anti-HIV Agents; Antineoplastic Agents; Antiviral Agents; Cell Division; Cell Line; Humans; Mice; Organophosphonates; Pyrimidine Nucleosides; Stereoisomerism; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication | 2002 |
5-Substituted-2,4-diamino-6-[2-(phosphonomethoxy)ethoxy]pyrimidines-acyclic nucleoside phosphonate analogues with antiviral activity.
Topics: Anti-HIV Agents; Antineoplastic Agents; Antiviral Agents; Cell Line; DNA Viruses; Humans; Nucleosides; Organophosphonates; Pyrimidines; Retroviridae; Structure-Activity Relationship | 2003 |
Inhibitory activities of three classes of acyclic nucleoside phosphonates against murine polyomavirus and primate simian virus 40 strains.
Topics: Animals; Antiviral Agents; Cell Line; Cidofovir; Cytosine; Mice; Microbial Sensitivity Tests; Nucleosides; Organophosphonates; Polyomavirus; Pyrimidine Nucleosides; Pyrimidines; Simian virus 40 | 2007 |
Selective inhibition of porcine endogenous retrovirus replication in human cells by acyclic nucleoside phosphonates.
Topics: Adenine; Amino Acid Sequence; Animals; Antiviral Agents; Catalysis; Cell Line; Dose-Response Relationship, Drug; Endogenous Retroviruses; HIV-1; Humans; Kidney; Molecular Sequence Data; Organophosphonates; Polymerase Chain Reaction; Protein Structure, Tertiary; Reverse Transcriptase Inhibitors; Stavudine; Swine; Swine, Miniature; Tenofovir; Virus Replication; Zidovudine | 2007 |
Activities of several classes of acyclic nucleoside phosphonates against camelpox virus replication in different cell culture models.
Topics: Adenine; Animals; Antiviral Agents; Cell Line; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Humans; Infant, Newborn; Male; Mice; Microscopy, Electron, Transmission; Nucleosides; Organophosphonates; Organophosphorus Compounds; Orthopoxvirus; Swiss 3T3 Cells; Virus Replication | 2007 |
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |